Enhancement of warfarin-induced hypoprothrombinemia by triclofos. 1972

E M Sellers, and M Lang, and J Koch-Weser, and R W Colman

UI MeSH Term Description Entries
D006993 Hypnotics and Sedatives Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. Hypnotic,Sedative,Sedative and Hypnotic,Sedatives,Hypnotic Effect,Hypnotic Effects,Hypnotics,Sedative Effect,Sedative Effects,Sedatives and Hypnotics,Effect, Hypnotic,Effect, Sedative,Effects, Hypnotic,Effects, Sedative,Hypnotic and Sedative
D007020 Hypoprothrombinemias Absence or reduced levels of PROTHROMBIN in the blood. Factor II Deficiency,Prothrombin Deficiency,Deficiency, Factor II,Hypoprothrombinemia,Deficiencies, Factor II,Deficiencies, Prothrombin,Deficiency, Prothrombin,Factor II Deficiencies,Prothrombin Deficiencies
D008297 Male Males
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D009994 Osmolar Concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent. Ionic Strength,Osmolality,Osmolarity,Concentration, Osmolar,Concentrations, Osmolar,Ionic Strengths,Osmolalities,Osmolar Concentrations,Osmolarities,Strength, Ionic,Strengths, Ionic
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D002713 Chlorine An element with atomic symbol Cl, atomic number 17, and atomic weight 35, and member of the halogen family. Chlorine Gas,Chlorine-35,Cl2 Gas,Chlorine 35,Gas, Chlorine,Gas, Cl2
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug

Related Publications

E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
July 1972, The Johns Hopkins medical journal,
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
March 1975, JAMA,
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
February 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
October 1970, The New England journal of medicine,
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
January 1976, The Journal of pharmacology and experimental therapeutics,
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
February 2003, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
June 1951, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
July 1971, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
June 2004, The Annals of pharmacotherapy,
E M Sellers, and M Lang, and J Koch-Weser, and R W Colman
August 1997, Journal of clinical pharmacology,
Copied contents to your clipboard!